Related Experiment Video
Updated: Oct 8, 2025
06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
521
[Stenting of uncomplicated type B aortic dissection]
Barbara Mildahl1, Jacob Budtz-Lilly, Hossain Mohit Mafi
1barbaramildahl@outlook.com.
Ugeskrift for Laeger
|January 4, 2022
Summary
Conservative treatment for type B aortic dissection has low short-term survival but high long-term risks. Combining medical therapy with thoracic endovascular aortic repair (TEVAR) may improve outcomes, but careful patient selection is crucial.
Area of Science:
- Cardiovascular Medicine
- Vascular Surgery
- Medical Technology
Background:
- Uncomplicated type B aortic dissection (TBAD) traditionally treated conservatively.
- Conservative management shows low short-term mortality but high long-term adverse events.
- This highlights a need for evaluating more aggressive therapeutic strategies.
Purpose of the Study:
- To review the risks and benefits of thoracic endovascular aortic repair (TEVAR) for TBAD.
- To identify patient characteristics influencing TEVAR outcomes.
- To inform improved patient selection for combined medical and endovascular treatment.
Main Methods:
- Literature review of studies comparing conservative treatment with TEVAR for TBAD.
- Analysis of data on short-term and long-term mortality and complication rates.
- Synthesis of evidence regarding risk-benefit profiles of TEVAR.
Main Results:
- Conservative treatment is linked to favorable short-term survival.
- Long-term outcomes under conservative management are often poor, with significant complication rates.
- Combined medical therapy and TEVAR show potential for improved prognosis in select patients.
Conclusions:
- TEVAR offers a potential alternative to conservative management for TBAD.
- Identifying specific patient risk factors and benefits is paramount for optimal TEVAR application.
- Further research is essential to refine patient selection criteria for TEVAR in TBAD.
